Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission

Brain Research

Volumn 712, Issue 2, 1996, Pages 179-189

  Sieb, Jörn P ^a   Milone, Margherita ^a   Engel, Andrew G ^a  

^a MAYO CLINIC   (United States)

Author keywords

acetylcholine receptor; channel block; chloroquine; neuromuscular transmission; patch clamp analysis; quinidine; quinine; transmitter release

Indexed keywords

CHLOROQUINE; NEOSTIGMINE; NICOTINIC RECEPTOR; QUINIDINE; QUININE; QUINOLINE DERIVATIVE; TUBOCURARINE CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM; ELECTROPHYSIOLOGY; MINIATURE ENDPLATE POTENTIAL; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PATCH CLAMP; PHRENIC NERVE; PRIORITY JOURNAL;

EID: 0029868615     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01349-0     Document Type: Article

References (69)

1. Adams, P.R., Transmitter action at endplate membrane. In: M.M. Salpeter (Ed.), The Vertebrate Neuromuscular Junction, Liss, New York, 1987, pp. 317-359.
2. Anderson, C.R. and Stevens, C.F., Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction, J. Physiol. (Lond.), 235 (1973) 655-691.
3. Balser, J.R., Roden, D.M. and Bennett, P.B., Single inward rectifier potassium channels in guinea pig ventricular myocytes. Effects of quinidine, Biophys. J., 59 (1991) 150-161.
4. Bennett, M.R. and Florin, T., A statistical analysis of the release of acetylcholine at newly formed synapses in striated muscle, J. Physiol. (Lond.), 238 (1974) 93-107.
5. 125I-α scorpion toxin. I. Preferential labeling of glial cells on the presynaptic side, J. Neurosci., 8 (1988) 1469-1478.
6. Brigant, J.L. and Mallart, A., Presynaptic currents in mouse motor endings, J. Physiol. (Lond.), 333 (1982) 619-636.
7. +-depolarized guinea-pig atria, Br. J. Pharmacol., 86 (1985) 7-17.
8. Brumback, R.A., The neuromuscular junction. Part II. Myasthenia gravis, Fam. Med., 23 (1981) 126-133.
9. Code, A.A., Code of Federal Regulations. Title 21; Section 172.575, U.S. Government Printing Office, Washington, D.C., 1990,
10. Colquhoun, D., Large, W.A. and Rang, H.P., An analysis of the action of a false transmitter at the neuromuscular junction, J. Physiol. (Lond.), 266 (1977) 361-395.
11. Colquhoun, D. and Ogden, D.C., Activation of ion channels in the frog end-plate by high concentrations of acetylcholine, J. Physiol. (Lond.), 395 (1988) 131-159.
12. Colquhoun, D. and Sakmann, B., Fast events in single channel currents activated by acetylcholine and its analogues at the frog muscle end-plate, J. Physiol. (Lond.), 369 (1985) 501-557.
13. Cook, N.S. and Quast, U., Potassium channel pharmacology. In: N.S. Cook (Ed.), Potassium Channels, John Wiley, New York, 1990, pp. 181-255.
14. Cull-Candy, S.G., Miledi, R. and Trautmann, A., End-plate currents and acetylcholine noise at normal and myasthenic human end-plates, J. Physiol. (Lond.), 287 (1979) 247-265.
15. Cull-Candy, S.G., Miledi, R., Trautmann, A. and Uchitel, O., On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates, J. Physiol. (Lond.), 299 (1980) 621-638.
16. del Castillo, J. and Katz, B., Quantal components of the end-plate potential, J. Physiol. (Lond.), 124 (1954) 560-573.
17. Dilger, J.P., Brett, R.S. and Lesko, L.A., Effects of isoflurane on acetylcholine receptor channels. 1. Single-channel currents, Mol. Pharmacol., 41 (1992) 127-133.
18. Dilger, J.P., Vidai, A.M., Mody, H.I. and Liu, Y., Evidence for direct actions of general anesthetics on an ion channel protein. A new look at a unified mechanism, Anesthesiology, 81 (1994) 431-442.
19. Dreyer, F., Acetylcholine receptor, Br. J. Anaesth., 54 (1982) 115-130.
20. Dreyer, F. and Penner, R., The actions of presynaptic snake toxins on membrane currents of mouse motor nerve terminals, J. Physiol. (Lond.), 386 (1987) 455-463.
21. Eaton, L.M., Diagnostic tests for myasthenia gravis with prostigmine and quinine, Proc. Staff. Meet. Mayo. Clin., 18 (1943) 230-246.
22. Elmqvist, D. and Quastel, D.M.J., A quantitative study of end-plate potentials in isolated human muscle, J. Physiol (Lond.), 178 (1965) 505-529.
23. Engel, A.G., Lambert, E.H. and Gomez, M.R., A new myasthénie syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release, Ann. Neurol., 1 (1977) 315-330.
24. Farley, J.M., Yeh, J.Z., Watanabe, S. and Narahashi, T., Endplate channel block by guanidine derivatives, J. Gen. Physiol., 77 (1981) 273-293.
25. Franke, U., Proksch, B., Müller, M., Risler, T. and Ehninger, G., Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated by haemofiltration, Eur. J. Clin. Pharmacol., 15 (1983) 471-479.
26. Frisk-Holmberg, M., Bergkvsit, Y., Domeij-Nyberg, N., Hellström, L. and Jansson, F., Chloroquine serum concentrations and side effects: evidence for dose-dependent kinetics, Clin. Pharmacol. Ther., 25 (1979) 345-350.
27. Gurney, A.M. and Rang, H.P., The channel blocking effect of methonium compounds on rat submandibular ganglion cells, Br. J. Pharmacol., 82 (1984) 623-642.
28. Gustafsson, L.L., Walker, O., Alvan, G. et al., Disposition of chloroquine in man after single intravenous and oral doses, Br. J. Clin. Pharmacol., 15 (1983) 471-479.
29. Hamill, O.P., Marty, A., Neher, E., Sakmann, B. and Sigworth, F.J., Improved patch clamp techniques for high resolution current recording from cells and cell-free membrane patches, Pflügers. Arch., 391 (1981) 85-100.
30. Harvey, A.M. and Whitehill, M.R., Quinine as an adjuvant to prostigmin in the diagnosis of myasthenia gravis. A preliminary report, Bull. Johns Hopkins Hasp., 61 (1937) 216-217.
31. Hearn, J. and Tiliakos, N.A., Myasthenia gravis caused by penicillamine and chloroquine therapy for rheumatod arthritis, South. Med. J., 79 (1986) 1185-1186.
32. Herrmann, A. and Gorman, A.L.F., Action of quinidine on ionic currents of molluscan pacemaker neurons, J. Gen. Physiol., 83 (1984) 919-940.
33. Kamenskaya, M.A., Elmqvist, D. and Thesleff, S., Guanidine and neuromuscular transmission 2. Effect on transmitter release in response to repetitive nerve stimulation, Arch. Neurol., 32 (1975) 510-518.
34. Kennedy, F. and Wolf, A., Experiments with quinine and prostig-mine in treatment of myotonia and myasthenia, Arch. Neurol. Psychiatr., 37 (1937) 68-74.
35. Kessler, K.M., Lowenthal, D.T., Warner, H., Gibson, T., Briggs, W. and Reidenberg, M.M., Quinidine elimination in patients with congestive heart failure or poor renal function, New Engl. J. Med., 290 (1974) 706-709.
36. Kornfeld, P., Horowitz, S.H., Genkins, G. and Papatestas, A.E., Myasthenia gravis unmasked by antiarrhythmic agents, Mt. Sinai. J. Med., 43 (1976) 10-14.
37. Koumi, S., Sato, R., Hayakawa, H. and Okumura, H., Quinidine blocks cardiac sodium current after removal of the fast inactivation process with chloramine-T, J. Mol. Cell. Cardiol., 23 (1991) 427-438.
38. Lang, B., Newson-Davis, J., Prior, C. and Wray, D.W., Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse, J. Physiol. (Lond.), 344 (1983) 335-345.
39. Magleby, K.L. and Stevens, C.F., The effect of voltage on the time course of end-plate currents, J. Physiol. (Lond.), 223 (1972) 151-171.
40. Magleby, K.L. and Stevens, C.F., A quantitative description of end-plate currents, J. Physiol. (Lond.), 223 (1972) 173-197.
41. Martin, A.R., Quantal nature of synaptic transmission, Physiol. Rev., 46 (1966) 51-66.
42. Masukawa, L.A. and Albuquerque, E.X., Voltage- and time-dependent action of histrionicotoxin on the endplate current of the frog muscle, J. Gen. Physiol., 72 (1978) 351-367.
43. McLoskey, K.L., Garriott, J.C. and Roberts, S.M., Quinine concentrations in blood following the consumption of gin and tonic preparations in a social setting, Anal. Toxicol., 2 (1978) 110-112.
44. Milone, M., Hutchinson, D.O. and Engel, A.G., Patch-clamp analysis of the properties of acetylcholine receptor channels at the normal human endplate, Muscle Nerve, 17 (1994) 1364-1369.
45. Miyamoto, M.D., Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions, J. Physiol. (Lond.), 250 (1975) 121-142.
46. Molgo, J. and Tabti, N., A review of drugs and toxins affecting presynaptic potassium currents and phasic transmitter release at motor nerve terminals, Acta. Physiol. Pharmacol. Latinoam., 39 (1989) 333-342.
47. Neely, A. and Lingle, C.J., Trapping of an open channel blocker at the frog neuromuscular acetylcholine channel, Biophys. J., 50 (1986) 981-986.
48. Neher, E. and Steinbach, J.H., Local anaesthetics transiently block currents through single acetylcholine-receptor channels, J, Physiol. (Lond.), 277 (1978) 153-176.
49. Ogden, D.C. and Colquhoun, D., Ion channel block by acetylcholine, carbachol and suberidylcholine at the frog neuromuscular junction, Proc. R. Soc. London. Ser. B., 225 (1985) 329-355.
50. Oosterhuis, H.J.G.H., Myasthenia gravis, Churchill Livingstone, Edinburgh, 1984, pp. 183.
51. Papke, R.L. and Oswald, E.O., Mechanism of noncompetitive inhibition of acetylcholine-induced single-channel currents, J. Gen. Physiol., 93 (1989) 785-811.
52. Robberecht, W., Bednarik, J., Bourgeois, P., VanHees, J. and Carton, H., Myasthenic syndrome caused by direct effect of chloroquin on neuromuscular junction, Arch. Neurol., 46 (1989) 464-468.
53. Sakmann, B., Patlak, J. and Neher, E., Single acetylcholine-activated channels show burst kinetics in the presence of desensitizing concentrations of agonist, Nature, 286 (1980) 71-73.
54. Schumm, F., Wiethölter, H. and Fateh-Moghadam, A., Myasthenie-Syndrome unter Chloroquin-Therapie, Dtsch. Med. Wochenschr., 106 (1981) 1745-1747.
55. Sghirlanzoni, A., Mantegazza, R., Mora, M., Pareyson, D. and Cornelio, F., Chloroquine myopathy and myasthenia-like syndrome, Muscle Nerve, 11 (1988) 114-119.
56. Sieb, J.P., Dengler, R. and Jerusalem, F., Das nichtparaneoplastische Lambert-Eaton-Syndrom, Nervenarzt., 63 (1992) 234-239.
57. Sigworth, F.J. and Sine, S.M., Data transformation for improved display and fitting of single-channel dwell time histograms, Biophys. J., 52 (1987) 1047-1054.
58. Sine, S.M., Quiram, P., Papanikolaou, F., Kreienkamp, H.-J. and Taylor, P., Conserved tyrosines in the a subunit of the nicotinic acetylcholine receptor stabilize quaternary ammonium groups of agonists and curariform antagonists, J. Biol. Chem., 269 (1994) 8808-8816.
59. Sine, S.M. and Taylor, P., Functional consequences of agonist mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells, J. Biol. Chem., 254 (1979) 3315-3325.
60. Stoffer, S.S. and Chandler, J.H., Quinidine-induced exacerbation of myasthenia gravis in patient with Graves' disease, Arch. Intern. Med., 140 (1980) 283-284.
61. Tattersall, J.E.H., Effects of organophosphorus anticholinesterases on nicotinic receptor ion channels at adult mouse muscle endplates, Br. J. Pharmacol., 101 (1990) 349-357.
62. Tattersall, J.E.H., Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro, Br. J. Pharmacol., 108 (1993) 1006-1015.
63. Varanda, W.A., Aracava, Y., Sherby, S.M., VanMeter, W.G., Eldefrawi, M.E. and Albuquerque, E.X., The acetylcholine receptor of the neuromuscular junction recognizes mecylamine as a noncompetitive agonist, Mol. Pharmacol., 28 (1985) 128-137.
64. Walls, T.J., Engel, A.G., Nagel, A.S., Harper, C.M. and Trastek, V.F., Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release, Ann. New York Acad. Sci., 681 (1993) 461-468.
65. Wernig, A., Estimates of statistical release parameters from crayfish and frog neuromuscular junctions, J. Physiol. (Lond.), 244 (1975) 207-221.
66. Wolter, M., Diagnostic der Myasthenia gravis, Dtsch. Med. Wochenschr., 101 (1976) 968-970.
67. Wörner, M., Gensler, M., Bahn, B. and Schreier, P., Anwendung der Festphasenextraktion zur raschen Probenvorbereitung bei der Bestimmung von Lebensmittelstoffen. I. Chinin in Getränken, Z. Lebensm. Unters. Forsch., 189 (1989) 422-425.
68. Zajtchuk, J.T., Mihail, R., Jewell, J.S., Dunne, M.J. and Chadwick, S.G., Electronystagmographic findings in long-term quinine ingestion. A preliminary report, Arch. Otolaryngol., 110 (1984) 788-791.
69. Zucker, R.S., Changes in the statistics of transmitter release during facilitation, J. Physiol. (Lond.), 229 (1973) 787-810.